Structuring the French biomanufacturing sector

Created under the aegis of the French State and the CSF-ITS (strategic committee for the health industries and technologies sector), France BioLead federates all links in the biodrug biomanufacturing value chain, including academic research, training, pharmaceutical & biotechnology companies, CDMOs & CROs1, equipment providers and clusters.

France BioLead’s objective is to build a unique biomanufacturing sector in France with the aims of making the country a European leader for the sector and easing access to therapeutic innovations.

Genopole is one of its founding members, along with other major actors such as ALLIS-NA, Capgemini, the CEA, Clean Biologics, Enosis Santé, France Biotech, GTP Bioways, Inserm, the Leem, Merck, Polepharma, Sanofi, Servier and Thermo Fisher Scientific.

1 CDMO: Contract Development Manufacturing Organizations | CRO: Contract Research Organizations